The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Suzdak Peter David since 2018.
The trader's CIK number is 1296629.
At the time of the last reporting, Suzdak Peter David was the Chief Executive Officer of Rexahn Pharmaceuticals, Inc.. (stock ticker symbol RNN).
Also see all insider trading activities at Rexahn Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | RNN | 0 | $0 | 0 | $0 | 6,250 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-02-28 | RNN | Option Ex | 6,250 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Suzdak Peter David (Chief Executive Officer of Rexahn Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.